Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenaline versus adrenaline for pre-hospital cardiogenic shock
ACTRN12621000805875Phase 3Recruiting
- Sponsor
- Ambulance Victoria
- Start
- Feb 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in cardiogenic shock comparing Noradrenaline with Adrenaline (2 arms). Primary endpoints: All-cause mortality and Refractory shock. Started Feb 2024; status: recruiting.
02
Drugs
norepinephrineepinephrine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on ACTRN12621000805875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000805875.